Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparison of next-generation sequencing and cobas EGFR mutation test v2 in detecting EGFR mutations.

Thoracic cancer - 1 Nov 2022

Murakami Shuji, Yokose Tomoyuki, Shinada Kanako, Isaka Testuya, Katakura Kengo, Ushio Ryouta, Kondo Tetsuro, Kato Terufumi, Ito Hiroyuki, Saito Haruhiro

Abstract excerpt

BACKGROUND: As the number of genetic mutations that must be tested increases, the Oncomine Dx Target test (ODxTT), which can simultaneously detect multiple cancer-related genes is becoming the main test used in preference to single-molecule testing. In this study, we evaluated the performance of ODxTT and cobas EGFR mutation test v2 (cobas EGFR), one of the single-molecule tests, in detecting EGFR mutations....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to High-Throughput Nucleotide Sequencing

Share to Lung Neoplasms

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 36203199
DOI: 10.1111/1759-7714.14685
PMCID: PMC9663664

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparison of next-generation sequencing and cobas EGFR mutation test v2 in detecting EGFR mutations.PMID 36203199Read ↗

Comparison of next-generation sequencing and cobas® EGFR Mutation Test v2 in detecting EGFR mutationsSemantic proximity Read ↗

Possible False Results With cobas® EGFR Mutation Test v2 and Oncomine Dx Target Test for EGFR Mutation.Semantic proximity Read ↗

Comparison of the analytical performance between the Oncomine Dx Target Test and a conventional single gene test for epidermal growth factor receptor mutation in non-small cell lung cancer.Semantic proximity Read ↗

Real-world data on NGS using the Oncomine DxTT for detecting genetic alterations in non-small-cell lung cancer: WJOG13019L.Semantic proximity Read ↗

Comparison of diagnostic performance between Oncomine Dx target test and AmoyDx panel for detecting actionable mutations in lung cancer.Semantic proximity Read ↗

Clinical utility of the Oncomine Dx Target Test multi-CDx system and the possibility of utilizing those original sequence data.Semantic proximity Read ↗

The association of EGFR amplification with aberrant exon 20 insertion report using the cobas EGFR Mutation Test v2.Semantic proximity Read ↗

Analytical performance of the cobas EGFR mutation assay for Japanese non-small-cell lung cancer.Semantic proximity Read ↗

A profile on cobas® EGFR Mutation Test v2 as companion diagnostic for first-line treatment of patients with non-small cell lung cancerSemantic proximity Read ↗

Comparison of cross-platform technologies for EGFR T790M testing in patients with non-small cell lung cancerSemantic proximity Read ↗

Simulation analysis of EGFR mutation detection: Oncomine Dx target test and AmoyDx panel impact on lung cancer treatment decisions.Semantic proximity Read ↗

Real-world evidence of the intrinsic limitations of PCR-based EGFR mutation assay in non-small cell lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.